Difference between revisions of "Interferon gamma-1b (Actimmune)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information") |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 4: | Line 4: | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information. |
==Diseases for which it was used== | ==Diseases for which it was used== | ||
| Line 10: | Line 10: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | * | + | * 1999-02-25: Initial FDA approval |
| + | |||
| + | == Patient Drug Information== | ||
| + | *[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf Interferon gamma-1b (Actimmune) Package Insert]<ref>[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf Interferon gamma-1b (Actimmune) Package Insert]</ref> | ||
==Also known as== | ==Also known as== | ||
*'''Brand name:''' Actimmune | *'''Brand name:''' Actimmune | ||
| + | |||
| + | ==References== | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Subcutaneous medications]] | [[Category:Subcutaneous medications]] | ||
| − | [[Category: | + | [[Category:Interferon gammas]] |
| − | [[Category: | + | |
| + | [[Category:Ovarian cancer medications (historic)]] | ||
[[Category:FDA approved in 1999]] | [[Category:FDA approved in 1999]] | ||
Latest revision as of 00:58, 29 June 2024
General information
Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways.
Route: SC
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.
Diseases for which it was used
History of changes in FDA indication
- 1999-02-25: Initial FDA approval
Patient Drug Information
Also known as
- Brand name: Actimmune